NIPPON INDIA PHARMA FUND vs PGIM INDIA HEALTHCARE FUND

Nippon vs PGIM· Portfolio Overlap Analysis

45.9%High Overlap
12 common stocksRank #14707 / 20,000

Investor takeaway: At 45.9% overlap, a significant part of these portfolios is identical. Despite coming from different AMCs, the stock picks still converge heavily. Make sure both funds actually serve different jobs in your allocation.

Common Holdings (12)

StockWt% in NIPPON INDIA PHARMAWt% in PGIM INDIA HEALTHCAREOverlap
Sun Pharmaceutical Industries Limited
Pharmaceuticals & Biotechnology
13.08%11.69%11.69%
Divi's Laboratories Limited
Pharmaceuticals & Biotechnology
6.56%10.34%6.56%
Dr. Reddy's Laboratories Limited
Pharmaceuticals & Biotechnology
5.81%6.09%5.81%
Max Healthcare Institute Limited
Healthcare Services
3.49%5.81%3.49%
Ajanta Pharma Limited
Pharmaceuticals & Biotechnology
3.41%4.94%3.41%
Mankind Pharma Limited
Pharmaceuticals & Biotechnology
3.06%5.01%3.06%
Sai Life Sciences Limited
Pharmaceuticals & Biotechnology
3.07%2.98%2.98%
Abbott India Limited
Pharmaceuticals & Biotechnology
2.37%3.18%2.37%
Dr. Lal Path Labs Limited
Healthcare Services
2.05%2.83%2.05%
JB Chemicals & Pharmaceuticals Limited
Pharmaceuticals & Biotechnology
1.98%6.39%1.98%
Cipla Limited
Pharmaceuticals & Biotechnology
5.67%1.62%1.62%
Anthem Biosciences Limited
Pharmaceuticals & Biotechnology
0.89%2.08%0.89%

Unique to NIPPON INDIA PHARMA

  • Lupin Limited7.99%
  • Apollo Hospitals Enterprise Limited5.17%
  • MedPlus Health Services Limited3.70%
  • Vijaya Diagnostic Centre Limited3.49%

Unique to PGIM INDIA HEALTHCARE

  • Aster DM Healthcare Ltd.7.07%
  • Rubicon Research Ltd.5.29%
  • Krishna Inst of Medical Sciences Ltd.4.35%

Sector Overlap Breakdown

Pharmaceuticals & Biotechnology
40.4% (10)
Healthcare Services
5.5% (2)

More comparisons for NIPPON INDIA PHARMA

More comparisons for PGIM INDIA HEALTHCARE

Overlap calculated on equity holdings only. Debt, government securities, and cash are excluded.